Despite mounting evidence, generated primarily in cardiovascular and neurodegenerative disorders (12, 13, 15, 27, 28), for the existence of different isoforms of CRP with distinct biological properties and direct effects within tissue, this study is the first to apply this emerging concept into the clinical setting of cancer patients. This evidence concerns the gene CRP and cancer.